New gene implicated in progression and recurrence of triple-negative breast cancer

A gene not previously associated with breast cancer appears to play a pivotal role in the growth and progression of triple-negative breast cancer.

Interval tumors found in six percent of colorectal cancer cases

Interval tumors found in six percent of colorectal cancer cases

Interval cancers more likely to be earlier stage, proximal, have lower risk of death

Germline EGFR T790M mutation indicates a high risk for familial NSCLC regardless of smoking

Two studies provide new insight into a germline epidermal growth factor receptor T790M mutation in familial non-small cell lung cancer, and suggest the need for tailored approaches for early detection and treatment.

Reliance on Windows XP may threaten data security

Reliance on Windows XP may threaten data security

Continued security of patient data is needed following Microsoft's termination of XP support.

Hope for preserving fertility in young boys with cancer

Scientists have moved a step closer to being able to preserve fertility in young boys who undergo chemotherapy and radiation treatments for cancer.

Perioperative chemotherapy increases bladder cancer survival

Perioperative chemotherapy increases bladder cancer survival

Study shows low utilization of bladder cancer perioperative chemotherapy is associated with a survival benefit in the general population.

Certain genetic variants increase recurrence risk for bladder cancer

Inheriting certain DNA sequences can affect the prognosis of bladder cancer patients, according to a new study.

Adult cancer drug offers hope against aggressive pediatric brain tumor

The quest to improve survival of children with a high-risk brain tumor has led investigators to two drugs already used to treat adults with breast, pancreatic, lung, and other cancers.

Video-based education increases men's skin awareness

Video-based education increases men's skin awareness

Those receiving intervention increased clinical skin exams in the seven months following their education.

Some breast cancer tumors hijack epigenetic machinery to evade drugs

A breast cancer therapy that blocks estrogen synthesis to activate cancer-killing genes sometimes loses its effectiveness because the cancer takes over epigenetic mechanisms, according to researchers.

Conference Coverage

AACR: Irregular Menstrual Cycles Tied to Ovarian Cancer Risk

Irregular menstrual cycles may be an early marker of ovarian cancer risk, according to a study presented at the annual meeting of the American Association for Cancer Research.

AACR: Coffee consumption may lower liver cancer risk

Increased coffee consumption may reduce hepatocellular carcinoma (HCC) risk across ethnicities, according to a study.

AACR: LY2835219 shows promise for metastatic breast cancer

The novel cell cycle inhibitor selective for the cyclin-dependent kinases CDK4 and CDK6 (CDK4/6), LY2835219, shows promise for metastatic breast cancer, according to a study.

Molecular subtyping of breast cancer can better identify women at high risk of recurrence

A method called molecular subtyping can help doctors better determine which of their breast cancer patients are at high risk of getting breast cancer again, according to a new study.

Reducing radiation therapy dose to bilateral submandibular lymph nodes improves salivary function

For head and neck cancer patients undergoing radiation therapy, a reduction in the amount of radiation treatment volume to the submandibular (level IB) lymph nodes resulted in better patient-reported salivary function.

Sign Up for Free e-newsletters

April Contest: Win a Pebble Watch

Start the contest today

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs